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Abstract. At present little is known of the biochemical 
machinery controlling transport of newly synthesized 
lysosomal hydrolases from the trans-Golgi network 
(TGN) to endosomes. The demonstration that Vps34p 
(a protein required for targeting soluble hydrolases to 
the vacuole in Saccharomyces cerevisiae) is a phosphati- 
dylinositol 3-kinase (PI3-K) suggested the possibility 
that a homologous enzyme might be involved in the 
equivalent step in mammalian cells. Using the PI3-K in- 
hibitors wortmannin and LY294002, I provide evidence 
to support this hypothesis. 
Treatment of K-562 cells with wortmannin induced 
secretion of procathepsin D, with half-maximal inhibi- 
tion of accurate targeting to lysosomes at 10-20 nM. 
Kinetic analysis indicated that a late Golgi (TGN) step 
was affected, and that other constitutive vesicular trans- 
port events were not. The M6P recognition signal was 
still generated in the presence of wortmannin suggest- 
ing that the drug was directly inhibiting export of the 
receptor-ligand complex from the TGN, while removal 
of the drug led to a rapid restoration of accurate sort- 
ing. At the concentrations used, wortmannin and 
LY294002 are presently accepted to be specific inhibi- 
tors of PI3-K. I conclude that these data implicate such 
an enzyme in the trafficking of M6P-receptor-ligand 
complexes from the TGN towards lysosomes. 
I 
N most mammalian  cells,  transport  of newly synthe- 
sized soluble acid hydrolases to lysosomes depends 
upon their recognition by receptors specific for man- 
nose 6-phosphate (M6P)  1  residues, and their subsequent 
sequestration into clathrin-coated regions of the trans-Golgi 
Network (TGN) (for reviews see von Figura and Hasilik, 
1986; Kornfeld and Mellman,  1989). The M6P modifica- 
tion appears unique to lysosomal hydrolases, and is formed 
by the concerted action of two enzymes, the first of which 
(UDP-GIcNAc: lysosomal enzyme N-acetylglucosamine-1- 
phosphotransferase)  recognizes  conformation-dependent 
protein determinants in the lysosomal enzyme (Baranski 
et al., 1991). Phosphorylation begins before export of the 
hydrolase from the endoplasmic reticulum, but continues 
during the passage of the protein through the Golgi appa- 
ratus  (Lazzarino  and  Gabel,  1988, 1989).  Subsequently 
N-acetylglucosamine-l-phosphate  a-N-acetylglucosamini- 
dase exposes the M6P recognition signal, allowing  sorting 
Please address all correspondence to H. W. Davidson,  Department of 
Clinical Biochemistry, University of Cambridge, Addenbrookes Hospital, 
Hills Road, Cambridge, CB2 2QR, England. Tel.: 44 1223 336746. Fax: 44 
1223 330598. 
1. Abbreviations used in this paper, ei-M6PR, cation-independent  M6P re- 
ceptor; M6P, mannose 6-phosphate; PI3-K, phosphatidylinositol  3-kinase; 
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to occur, most probably in the TGN (Duncan and Korn- 
feld, 1988). 
Two distinct M6P receptors have been identified,  charac- 
terized, and cDNAs encoding them cloned and sequenced. 
Both receptors are integral membrane glycoproteins and 
have similar binding specificities for M6P containing ligands, 
but vary in their subunit  size, ability to endocytose exoge- 
nous ligands,  and their relative importance in delivering 
particular  acid hydrolases (Kornfeld and Mellman, 1989; 
Ludwig et al., 1994). The larger of the two, the 300-kD cat- 
ion-independent M6P receptor (ci-M6PR), is also the re- 
ceptor for  insulin-like  growth  factor  II  (Morgan  et  al., 
1987), and is the more widely studied. Its distribution at 
steady state appears to vary between individual cell types, 
but in most cases it is concentrated in the TGN and prely- 
sosomal late endocytic compartments (PLCs) (Griffiths et 
al., 1988; Kornfeld and Mellman, 1989), consistent with a 
role in transporting  ligands between these two compart- 
ments, although the initial  site of delivery may be an ear- 
lier endocytic compartment (Ludwig et al., 1991). Within 
PLCs the acidic  pH will induce dissociation of receptor- 
ligand complexes allowing the receptors to be recycled to 
the  TGN  where  they  can  bind  additional  hydrolases 
(Brown et al., 1986; Duncan and Kornfeld, 1988; Goda and 
Pfeffer, 1988). Consistent with this itinerary, both immu- 
nocytochemical  and  biochemical  analyses  indicate  that 
dense lysosomes are devoid of ci-M6PRs (Griffiths et al., 
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cells with permeant weak bases causes hypersecretion of 
acid hydrolases due to the recycling of occupied M6P re- 
ceptors to the TGN (von Figura and Hasilik, 1986). 
A  small proportion (typically ~10%) of the total popu- 
lation of ci-M6PRs in most cells is located at the cell sur- 
face. These receptors can endocytose extracellular M6P 
containing ligands,  deliver them  via  PLCs to lysosomes 
(von Figura  and  Hasilik,  1986;  Kornfeld and  Mellman, 
1989), and subsequently also recycle to the TGN (Duncan 
and Kornfeld, 1988). Approximately 10% of receptors re- 
cycled to the TGN from the cell surface subsequently re- 
appear at the plasma membrane (Jin et al., 1989), suggest- 
ing that  all  ci-M6PRs  belong to  a  common pool which 
mediates both endogenous and exogenous delivery to ly- 
sosomes. However, as growth of cells in M6P containing 
media does not inhibit delivery of newly synthesized acid 
hydrotases to lysosomes, it is unlikely that the majority of 
lysosomal  enzymes  are  delivered via  the  plasma  mem- 
brane (von Figura and Hasilik, 1986). 
In the TGN, M6P receptors are sequestered into clath- 
rin-coated regions associated with the AP1 adaptor com- 
plex, which subsequently bud to form clathrin-coated vesi- 
cles (yon Figura and Hasilik, 1986; Kornfeld and Mellman, 
1989; Pearse and Robinson,  1990).  Consistent with their 
role in mediating the transport of newly synthesized lyso- 
somal  hydrolases,  isolated  clathrin-coated  vesicles  also 
contain these proteins, which are present exclusively as the 
proenzymes and, at least to some extent, membrane asso- 
ciated  in  a  M6P-dependent  fashion  (Marquardt  et  aL, 
1987; Schulze-Lohoff  et al., 1985). The formation of TGN- 
derived  clathrin-coated  vesicles  appears  constitutive.  It 
does not  require  the  presence of cargo (Braulke  et al., 
1987), and may also not require the presence of the recep- 
tor. In vitro, ci-M6PR cytoplasmic tails can directly interact 
with isolated AP1  adaptors  (Glickman et al.,  1989)  sug- 
gesting that they may be directly involved in the recruit- 
ment of coat proteins to the TGN. However, the interac- 
tion is of relatively low affinity, and recent evidence has 
implicated other TGN membrane proteins in the recruit- 
ment of AP1 adaptors (Mallet, W. G., and F. M. Brodsky. 
1994. Membrane protein binding to the clathrin coat pro- 
tein AP1. Mol. Biol. Cell. 5:S:329a; Seaman, 1995). In addi- 
tion, M6P-dependent targeting of lysosomal enzymes oc- 
curs in ci-M6PR deficient fibroblasts (Ludwig et al., 1994), 
implying that this receptor is not essential for the forma- 
tion of clathrin-coated vesicles from the TGN. 
Despite the considerable amount of knowledge relating 
to the intracellular itineraries of newly synthesized acid 
hydrolases and M6P receptors, and the structure and as- 
sembly of the clathrin coat, much less is known of the mo- 
lecular machinery governing vesicular transport between 
the  TGN  and  endosomes. For other vesicular transport 
events, the biochemical machinery regulating movement 
between  compartments  of  the  eukaryotic  cell  appears 
highly conserved, with many examples of homologous pro- 
teins acting at equivalent steps in both yeast and mamma- 
lian cells (for review see Pryer et al., 1992). Although yeast 
lack highly acidic endosomes and lysosomes, the vacuole 
performs a similar role to mammalian lysosomes (for re- 
view see Klionsky et al.,  1990), and may be functionally 
equivalent. Transport of soluble hydrolases to the vacuole 
is also receptor mediated and involves delivery to prevacu- 
olar endocytic compartments (Vida et al.,  1993), raising 
the possibility that it may occur by a similar mechanism to 
lysosomal transport, and that related proteins may govern 
movement of soluble hydrolases between the late Golgi 
and endosomes in all eukaryotes. Genetic studies have im- 
plicated at least 50 gene products in vacuolar protein sort- 
ing (Klionsky et al.,  1990)  but in most cases mammalian 
homologues remain  to  be  identified,  or  have  yet to  be 
shown to have a role in lysosomal enzyme transport. 
Recently, following the demonstration that the product 
of the VPS34 gene is a phosphatidylinositol 3-kinase (PI3- 
K) (Herman and Emr, 1990; Schu et al.,  1993),  attention 
has been focussed upon the potential involvement of lipid 
kinases in vesicular trafficking events. The vps34 mutant 
aberrantly secretes vacuolar hydrolases such as carboxy- 
peptidase Y in their proenzyme forms, indicating that it se- 
lectively blocks movement between the Golgi and vacuole 
without affecting secretion of proteins destined for the ex- 
tracellular space. Consequently, if a homologous protein is 
involved in  transport  to  lysosomes,  a  likely phenotype 
would be hypersecretion of acid hydrolase proenzymes. I 
now report that the flmgal metabolite wortmannin, and the 
structurally unrelated compound LY294002, at doses com- 
patible with the inhibition of PI3-K activity, cause hyper- 
secretion of procathepsin D from human K-562 cells, con- 
sistent with the hypothesis that transport to lysosomes in 
mammalian cells requires the action of a lipid kinase. 
Materials and Methods 
Reagents 
Tissue culture  media and  supplements were  purchased from GIBCO- 
BRL (Paisley, Scotland). Wortmannin was purchased from Sigma (Poole, 
UK) reconstituted to 1 mM in DMSO and stored as aliquots at -20°C. 
LY294002 was generously provided by Dr.  P.  Shepherd (University of 
Cambridge) and reconstituted at 10 mg/ml in DMSO. All other reagents 
were obtained from Sigma except where indicated. 
Cells and Antibodies 
K-562 cells (Lozzio and Lozzio, 1975)  were obtained from Mrs. A. Mur- 
rell, Department of Haematology (University of Cambridge, Cambridge, 
UK) and maintained in RPMI 1640 supplemented with 10% vol/vol FCS, 
2 mM glutamine, 20 mM Na pyruvate, 50 U/ml penicillin, 50 i~g/ml strep- 
tomycin, and 1% minimal essential medium nonessential amino acids in a 
95% air, 5% CO2 humidified incubator at 37°C. 
A  rabbit polyclonal antiserum recognizing all forms of human cathep- 
sin D was obtained from Dako (High Wycombe, UK). 
Biosynthetic Radiolabeling 
Cells were collected from culture by centrifugation (250  g; 4 rain at room 
temperature) and washed once with PBS containing 5 mg/ml BSA (PBS/ 
BSA). After resuspension in methionine free a-MEM (Sigma) containing 
2.2 g/1 Na bicarbonate and 5 % volJvol dialyzed new-born calf serum (1.5 × 
106 cells/ml) they were incubated for 1 h at 37°C in a gassed incubator to 
deplete endogenous methionine. They were then collected, washed once 
with PBS and resuspended in methionine free ct-MEM containing 20 mM 
Na Hepes, pH 7.4 (5 ×  107 cellslml), and incubated at 37°C for 5 rain with 
250 txCi TransaSS-Label (ICN Biomedicals Ltd., Thame, UK). The cells 
were then transferred to ice, washed twice with ice cold PBS/BSA, and fi- 
nally resupended at 2.5 ×  106 cells/ml in RPMI 1640 containing 20 mM Na 
Hepes, pH 7.4, 3 mM methionine, and 1% vol/vol undialyzed serum, with 
or without 5  mM M6P and inhibitors as indicated. Aliquots (2.5  ×106 
cells) were incubated at 37°C for various times,  the cells and medium col- 
lected by centrifugation, and radiolabeled cathepsin D  immunoprecipi- 
tared as described below. 
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Cells were lysed in 500 p~l of 50 mM Tris-HC1,  pH 7.4, containing 150 mM 
NaCl, 1% (wt/vol) Triton X-100, 1 mM EDTA, 1 mM PMSF, 50 IxM leu- 
peptin, 50 ixM E-64, I  IxM pepstatin A, and 10 ixg/rnl chymostatin for 10 
min at 0°C. After centrifugation (25,000 g; 10 min at 4°C) 5  ~1 of rabbit 
anti-(human cathepsin D) was added to the supernate, and the mixture in- 
cubated overnight at 4°C. Immune complexes were collected using 20 ILl 
protein A-agarose (Sigma), washed three times with 50 mM Tris-HCl, pH 
7.5, containing 150 mM NaC1, 1% (wt/vol) Triton X-100, 1% (wt/vol) Na 
deoxycholate, 0.1% SDS, and 5 mM EDTA, once with 10 mM Tris-HC1, 
pH 6.8, and eluted with 50 p~l of 1.1-fold concentrated SDS-PAGE sample 
buffer lacking reducing agents by heating to  100°C for 10 min. Eluates 
were  analyzed  by  SDS-PAGE  using  10%  gels,  fixed  for  10  min  in 
45%(vol/vol) methanol, 10%(vol/vol) acetic acid, dried, and radioactivity 
determined using a Fuji Bas2000 phosphoimager. 
To one half of the total incubation media leupeptin (100 p.M), E-64 (50 
p~M), and PMSF (1 mM) were added from concentrated stock solutions. 
The resulting mixtures were then centrifuged (25,000  g;, 10 rain at 4°C), 
and the supernatants subsequently treated identically to the clarified cell 
lysates. 
Results 
Wortmannin Causes Mistargeting  of Procathepsin  D 
Cathepsin  D  is  the  major mammalian aspartyl protease 
and provides the most widely studied example of M6P de- 
pendent lysosomal enzyme targeting (for review see Korn- 
feld and Mellman, 1989). In human cells it is synthesized 
as an Mr 53-kD proenzyme containing  two N-linked oli- 
gosaccharides which are modified by the addition of one 
or more M6P residues  to provide the  recognition  signal 
(Hasilik and Neufeld, 1980a). After export from the TGN 
and delivery to endosomal compartments, the propeptide 
is removed to form a 47-kD intermediate, which is subse- 
quently cleaved in lysosomes to form the mature enzyme 
comprising  noncovalently  associated  31-kD  and  14-kD 
polypeptides  (Delbr0ck  et  al.,  1994;  Gieselmann  et  al., 
1983; Rijnboutt et al., 1992). 
Preliminary experiments demonstrated that the matura- 
tion  of  cathepsin  D  in  erythroleukaemic  K-562  cells 
showed  similar  kinetics  to  those  observed  in  other  cell 
lines  (Gieselmann  et  al.,  1983;  Hasilik  and  Neufeld, 
1980b). Thus after pulse radiolabeling for 5 min, the 53-kD 
protein was the sole form of cathepsin D  detected in the 
first 20-30 min of chase. Subsequently the 47-kD interme- 
diate was generated, reached a maximum after 90-120 min 
and  thereafter  declined,  while  the  mature  31-kD  form 
could not be detected in the first 60 min of chase but be- 
came the major form after 2-4 h. To investigate the poten- 
tial role of PI3-K activity in the transport of lysosomal en- 
zymes K-562 cells were pulse radiolabeled and chased for 
4 h  in the presence or absence of wortmannin (100 nM). 
M6P (5 mM) was included in the chase medium to inhibit 
any endocytosis of secreted proenzyme. As shown in Fig. 
1,  treatment  with this  drug  almost completely abolished 
the intracellular maturation of cathepsin D  (lanes 2 and 3), 
resulting  instead  in  almost  quantitative  recovery of the 
proenzyme from the chase medium (lanes 4 and 5). A  sim- 
ilar result was observed in several other cell lines tested in- 
cluding NRK cells stably transfected with human cathep- 
sin  D,  and  Cos  1  cells,  although  in  these  cases  a  much 
higher degree of basal procathepsin D  secretion in the ab- 
sence of the drug was also observed (data not shown). 
Figure 1. Sorting of procathepsin D in the presence of wortman- 
nin. K-562 cells were pulse radiolabeled and chased for times as 
indicated  in the presence of extracellular  M6P (5 mM) and pres- 
ence or absence of wortmannin (100 nM). Cells and media were 
collected, and cathepsin  D immunoprecipitated and analyzed by 
SDS-PAGE as described  in Materials  and Methods.  Positions  of 
procathepsin D (Pro), the 47-kD intermediate (Int), and the ma- 
ture 31-kD heavy chain (Mat) are indicated. 
Mistargeting Probably Involves Inhibition  of a PI3-K 
Although at low nanomolar concentrations wortmannin is 
presently considered to be a specific inhibitor of PI3-K ac- 
tivity (Arcaro and Wymann, 1993;  Powis et al.,  1994),  at 
higher concentrations it can also inhibit other enzymes in- 
cluding myosin light chain kinase (Nakanishi et al., 1992). 
To investigate whether or not the observed mistargeting of 
procathepsin D  was consistent with the involvement of a 
PI3-K in lysosomal enzyme transport I examined the dose 
dependence of this effect. As shown in Fig. 2, wortmannin 
is an extremely potent inhibitor of lysosomal transport in 
K-562 cells, with a  half maximal effect at 10-20 nM. For 
the same cell line, an identical response was obtained us- 
ing several different batches of the drug. However the re- 
lationship  appeared to  be cell specific,  and  some of the 
other cell lines tested required up to 50-100 nM wortman- 
nin to cause half-maximal mistargeting (data not shown). 
In these circumstances inhibition was only 70-80%  com- 
plete  at 250 nM,  the  highest concentration  tested in this 
study. 
Nevertheless,  the  dose  respose  relationship  described 
above strongly implicates the involvement of a PI3-K in ly- 
sosomal trafficking in K-562 cells, although the possibility 
that  an  alternative  target  exists  cannot  be  completely 
eliminated.  Recently a  structurally  unrelated  compound, 
LY294002 has also been shown to be a selective inhibitor 
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Figure 2. Concentration dependence of wortmannin-induced mis- 
targeting. K-562 cells were pulse radiolabeled and chased for 2 h 
in the presence of extracellular M6P (5 mM) and wortmannin at 
the concentrations indicated. In each case the final concentration 
of DMSO was 0.1%. Cells and media were collected, cathepsin D 
immunoprecipitated,  and analyzed by SDS-PAGE and phospho- 
imaging as described in Materials and Methods. Results are ex- 
pressed as the percentage  of the total radiolabeled  cathepsin D 
recovered from the medium (i) or in cell-associated processed 
forms (rq). 
of PI3-K (Vlahos et al., 1994), albeit at doses in the micro- 
molar range. To further test my hypothesis that a PI3-K is 
involved in lysosomal enzyme trafficking, I examined the 
effect  of this  drug.  As  shown in  Fig.  3,  LY294002  also 
caused mistargeting of procathepsin D  with a  half-maxi- 
mal effect at 40-50 IxM. At this dose the drug also appears 
to selectively target PI3-K activities (Vlahos et al.,  1995), 
consistent with the conclusion that inhibition  of such an 
activity is responsible for the drug induced mistargeting of 
procathepsin D I observe. 
Wortmannin Inhibits Segregation of Procathepsin D 
from the Constitutive Secretory Pathway 
In studies of the effect of wortmannin and LY294002 on 
other cellular events, such as the respiratory burst and glu- 
cose transporter translocation, it has been shown that inhi- 
bition can readily be observed within 5 min of the addition 
of the drugs (e.g., Arcaro and Wymann, 1993; Shepherd et 
al., 1995; Vlahos et al., 1995). Consequently, as addition of 
these drugs to K-562 cells  at a  time when virtually all of 
the radiolabeled cathepsin D  was still in the endoplasmic 
reticulum  resulted  in  hypersecretion  of  the  proenzyme 
(Figs.  1-3) this strongly suggests that at the concentrations 
used,  they  do  not  inhibit  vesicular  transport  either  be- 
tween  the  endoplasmic reticulum  and  Golgi,  within  the 
Golgi stack, or between the Golgi and plasma membrane. 
To examine more closely the subcellular location of the 
events in cathepsin D maturation sensitive to PI3-K inhib- 
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Figure 3.  Inhibition  of procathepsin  D  sorting  by LY294002. 
K-562 cells were pulse radiolabeled  and  chased for 2 h in the 
presence of extracellular M6P (5 mM) and LY294002 at the con- 
centrations  indicated.  In each  case  the  final concentration  of 
DMSO was 0.25%. Ceils and media were collected, cathepsin D 
immunoprecipitated, and analyzed by SDS-PAGE and phospho- 
imaging as described in Materials and Methods. Results are ex- 
pressed as the percentage  of the total radiolabeled  cathepsin D 
recovered from the medium (ia) or in cell-associated processed 
forms ([~). 
itors, K-562 cells  were pulse  radiolabeled for 5 min and 
chased for a total of 2 h. At various times wortmannin was 
added to a final concentration of 100 nM and the incuba- 
tion  continued for the  remainder  of the  2-h period.  As 
shown in Fig. 4, complete inhibition of processing was ob- 
served when the drug was added within the first 20-30 min 
of chase, after which there was a progressive decrease in 
the  amount of the  proenzyme secreted  (closed squares) 
and concoitant increase in the amount of processed intrac- 
ellular forms (open squares and closed triangles). Such ki- 
netics  are  consistent  with  the  inhibition  of a  late  Golgi 
event, and suggest that the major effect of wortmannin on 
cathepsin D  maturation is to inhibit its segregation from 
the constitutive secretory pathway in the TGN. At no time 
point was a selective accumulation of the 47-kD intermedi- 
ate form of cathepsin D  observed (compare open squares 
with closed triangles)  and for the later time points, there 
was  a  significant  increase  in  the  amount  of  processed 
cathepsin D  detected  at  the  end  of the  incubation over 
that present at the time that the wortmannin was added. 
This suggests that under the conditions used wortmannin 
does not inhibit processing of procathepsin D  per se, nor 
prevents  movement between  endosomes and  lysosomes, 
but rather acts at a single point in the lysosomal trafficking 
pathway. 
Wortmannin Does Not Prevent the Formation of the 
M6P Recognition  Signal 
The data described above strongly suggest that wortman- 
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Figure  4.  Time  course  of  wortmannin-induced  mistargeting. 
K-562 cells were pulse  radiolabeled and chased for 2 h  in  the 
presence of extracellular  M6P  (5 mM). At the times indicated 
wortmannin (100 nM) was added, and the incubation  continued 
for the remainder of the 2-h period. Cells and media were collected, 
cathepsin D  immunoprecipitated, and analyzed by SDS-PAGE 
and phospho-imaging as described in Materials and Methods. Re- 
suits  are expressed as the percentage of the total radiolabeled 
cathepsin D recovered from the medium (11) or in cell-associated 
intermediate  (I-1)  and mature (A) forms. 
nin  prevents sorting  of newly synthesized  lysosomal en- 
zymes from the constitutive secretory pathway. Since seg- 
regation  is  receptor  mediated  and  depends  upon  the 
formation of the  M6P  recognition  signal  (Kornfeld  and 
Mellman, 1989), one possible explanation for my observa- 
tions would be that this signal is not correctly formed in 
the presence of the drug. Studies of the phosphorylation of 
13-glucuronidase  in  a  murine  macrophage  cell  line  indi- 
cated that this modification could be detected within 15- 
20 min of the synthesis of the  enzyme but continued for 
the next 40-80 min (Goldberg and Kornfeld, 1981). Thus 
the kinetic data shown in Fig. 4 do not completely elimi- 
nate this possible explanation of the effect of wortmannin 
on cathepsin D  maturation. I therefore decided to directly 
examine the ability of procathepsin D  synthesized in the 
presence of wortmannin to bind to M6P receptors. 
Medium from K-562 cells pulse radiolabeled and chased 
in the presence of wortmannin  but  absence of M6P was 
collected  and  concentrated  fivefold by ultrafiltration.  It 
was then applied to unlabeled cells freshly collected from 
culture. After incubation overnight at 37°C in the presence 
or absence of extracellular M6P (5 mM), cells and media 
were collected and radiolabeled cathepsin D  analyzed by 
immunoprecipitation and SDS-PAGE. Under these condi- 
tions, cells incubated in the absence of exogenous M6P en- 
docytosed and processed N13 % of the added procathepsin 
D  (Fig. 5, track 1). This was reduced to 1.4% by inclusion 
of the phosphorylated sugar (track 2) consistent with the 
hypothesis that  endocytosis was largely dependent  upon 
ci-M6PRs  and  hence  that  wortmannin  does  not  prevent 
the synthesis of the recognition signal. As expected, whereas 
Figure 5. Endocytosis  of procathepsin D secreted in the presence 
of wortmannin.  K-562 cells (2.5 x  107) were pulse  radiolabeled 
and chased for 2 h in the presence of wortmannin (100 nM) as de- 
scribed  in Materials  and Methods,  except that the media con- 
tained Na bicarbonate instead of Na Hepes, and the chase incu- 
bation was conducted  in  a gassed  incubator.  The medium was 
collected, concentrated fivefold by ultra-filtration  using a centri- 
con-30  concentrator  (Amicon Ltd.,  Stonehouse,  UK), and  ap- 
plied to freshly isolated cells (2.5 x  106) in the absence or pres- 
ence of M6P (5 mM) as indicated.  After incubation  in a gassed 
incubator for 14 h cells and media were collected,  cathepsin  D 
immunoprecipitated and analyzed by SDS-PAGE as described in 
Materials  and Methods.  Positions  of procathepsin D  (Pro),  the 
47-kD  intermediate  (Int),  and  the  mature  31-kD  heavy chain 
(Mat) are indicated. 
the mature enzyme was the major cell associated form of 
radiolabeled cathepsin D, the proenzyme was the sole form 
recovered from the media after overnight incubation (Fig. 
5,  lanes 3  and  4).  Additional  experiments  demonstrated 
that procathepsin D  secreted in response to wortmannin 
could bind directly to immuno-affinity isolated human ci- 
M6PRs (data not shown), consistent with the major role of 
this receptor in the targeting of cathepsin D  to lysosomes 
(Ludwig et al., 1994). 
I  next examined the effect of excluding M6P from the 
chase medium.  As  shown  in  Fig.  6,  the  presence  of the 
ligand had only a minor effect upon the amount of proen- 
zyme recovered in the chase medium (stippled bars) or pro- 
cessed intracellularly (striped bars)  during a  2-h chase in 
the absence of wortmannin.  In contrast there was an ap- 
proximate twofold decrease in "secreted" proenzyme and 
increase  in  processed cathepsin  D  between cells treated 
with the drug in the absence and presence of the competing 
ligand. The most likely interpretation of this observation is 
that in the absence of the competing phosphorylated sugar 
procathepsin  D  secreted in  response to wortmannin  can 
bind to, and be endocytosed by, cell surface ci-M6PRs, and 
subsequently be transported  to lysosomes. Consequently 
these data again suggest that wortmannin does not prevent 
the formation of the recognition signal, and also imply that 
Davidson PI 3-Kinase Involvement in Lysosomal Enzyme Transport  801 Figure 6. Effect of extracellular M6P on wortmannin-induced  mis- 
targeting. K-562 cells were pulse radiolabeled and chased for 2 h 
in the absence or presence of wortmannin (100 nM) and extracel- 
lular M6P (5 mM) as indicated. Cells and media were collected, 
cathepsin D  immunoprecipitated, and analyzed by SDS-PAGE 
and phospho-imaging as described in Materials and Methods.  Re- 
sults  are expressed  as the percentage of the total radiolabeled 
cathepsin D recovered from the medium (m) or in cell-associated 
processed forms ([]). 
at  the  doses used the  drug does  not significantly inhibit 
binding of  procathepsin D  to  M6P  receptors,  receptor- 
mediated endocytosis or trafficking to lysosomes through 
the endocytic pathway. This latter conclusion is not incon- 
sistent with the observation that there was a  decrease in 
the percentage of cell-associated processed cathepsin D  in 
wortmannin-treated  cells incubated in the absence of M6P 
as compared to control cells, since this is unlikely to result 
from a direct effect of the drug on trafficking or processing 
within the endocytic pathway. Instead it is almost certainly 
a consequence of the kinetic nature of the assay, and the 
longer time taken for material secreted into the medium to 
reach  processing  compartments  after  receptor-mediated 
endocytosis as compared to the direct transport to endo- 
somes which occurs in the absence of wortmannin. 
Inhibition of Cathepsin D Segregation  Is Reversible 
In previous studies of the effects of wortmannin on cellu- 
lar processes, conflicting results have been obtained con- 
cerning whether or not the inhibition  is reversible (Clarke 
et al., 1994; Thelen et al., 1994; Woscholski et al., 1994). I 
therefore decided to examine whether or not the inhibi- 
tion  of  cathepsin  D  targeting  to  lysosomes  induced by 
wortmannin could be  reversed  by removal of the  drug. 
Cells were first pulse radiolabeled and chased for 1 h  in 
the presence or absence of wortmannin (100 nM). They 
were then collected, resuspended in fresh medium and in- 
cubated for an additional 2 h in the presence or absence of 
Figure 7. Reversal of the inhibition of procathepsin D sorting by 
wortmannin.  K-562 cells were pulse radiolabeled and chased for 1 h 
in the absence of M6P and the absence or presence of wortman- 
nin (100 nM) as indicated. Cells and media were collected,  and 
the 0-60 min media retained. The cells were washed once with 
ice-cold  PBS/BSA,  resuspended  in  fresh  medium  containing 
wortmannin if indicated, and chased for an additional 2 h.  (A) 
Cathepsin D  was immunoprecipitated from the respective 0-60 
min and 60-180  min media, and analyzed by SDS-PAGE, and 
phospho-imaging as described in Materials and Methods. Results 
are expressed as the percentage of the total radiolabeled cathep- 
sin D recovered from the cells and media present in the 0450 min 
([]) or 60-180  min (In) media samples.  (B) Cell-associated ca- 
thepsin D was immunoprecipitated and analyzed by SDS-PAGE 
and phospho-imaging as described in Materials and Methods. Re- 
sults  are expressed as the percentage of the total radiolabeled 
cathepsin D  from the cells and media recovered as mature ca- 
thepsin D. 
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of the total radiolabel was released into the chase medium 
during the first 60 min of chase (Fig. 7 A columns 1 and 2, 
striped bars), while 22% was released in the same period in 
the presence of the drug (A columns 3 and 4, striped bars). 
An additional 30% of the total-radiolabeled cathepsin D 
was released during the 60-180-min chase period when wort- 
mannin was included in the  second chase medium, irre- 
spective of whether or not it had been included in the first 
incubation (A  columns 2  and 4, stippled  bars),  however 
only 8%  was  released from cells previously exposed to 
wortmannin if the second chase medium lacked the inhibi- 
tor (A column 3, stippled bar). A complementary effect on 
the efficiency of procathepsin D  processing was also ob- 
served (B) consistent with the conclusion that the inhibi- 
tion was rapidly reversed and the population of newly syn- 
thesized  molecules,  which  had  not  passed  beyond  the 
TGN when the drug was removed, were subsequently cor- 
rectly sorted and delivered. Recovery could not be attrib- 
uted to release of a  cohort of molecules retained in the 
TGN as no significant pool of cell-associated procathepsin 
D  could be  detected after long term incubations  either 
when the drug was added directly (Fig. 1) or later during 
the chase period (data not shown). Nonetheless, together 
the data presented above suggest that wortmannin acts se- 
lectively in the exocytic pathway to inhibit the M6P depen- 
dent sorting of newly synthesized lysosomal hydrolases in 
the TGN. 
Discussion 
The results described above demonstrate that treatment of 
human K-562 cells with low nanomolar concentrations of 
the fungal metabolite wortmannin causes almost complete 
mistargeting of procathepsin D. A  similar effect was also 
observed with low micromolar concentrations of the struc- 
turally unrelated compond LY294002. At the doses used 
these drugs are currently believed to be specific inhibitors 
of PI3-K activity (Arcaro and Wymann, 1993; Powis et al., 
1994). Thus the most reasonable explanation of these ob- 
servations is that they demonstrate the involvement of a 
PI3-K in the delivery of newly synthesized acid hydrolases 
to lysosomes. The effect was selective for lysosomal target- 
ing: vesicular transport between the  endoplasmic reticu- 
lum and Golgi, within the Golgi stack, between the TGN 
and the cell surface, and within the endocytic pathway ap- 
peared to be unaffected. This latter observation does not 
contradict a recent report implicating a PI3-K in the en- 
docytic trafficking of activated PDGF receptors (Joly et 
al., 1994) since in this case the target appeared to be p110~ 
and to involve the tyrosine kinase dependent events asso- 
ciated with ligand-activated receptors.The ci-M6PR lacks 
tyrosine kinase activity and so only constitutive endocyto- 
sis was examined in the present study. 
Newly synthesized lysosomal enzymes are sorted from 
the constitutive secretory pathway in the TGN (von Figura 
and Hasilik, 1986; Kornfeld and Mellman, 1989). The ki- 
netic data, and the fact that only procathepsin D  was re- 
covered from the medium, strongly suggest that PI3-K in- 
hibitors disrupt these sorting events and act at the level of 
the TGN. Substantial wortmannin-induced secretion was 
observed in the absence of extracellular M6P. This sug- 
gests that the majority of procathepsin D  was not deliv- 
ered to the cell surface in association with M6P receptors 
(if this were the case the high affinity of the ligand for its 
receptor would likely have ensured that it remained cell 
associated and was subsequently reendocytosed), and that 
the main effect of the external M6P was to prevent associ- 
ation  of secreted procathepsin D  with surface ci-M6PR 
rather than displace ligand  from aberrantly targeted re- 
ceptors. It  also makes it unlikely that  the major site of 
wortmannin action is  an early endosomal compartment. 
Given that under normal circumstances newly synthesized 
acid  hydrolases may be  delivered from the  TGN to  an 
early endocytic compartment (Ludwig et al.,  1991; Rijn- 
boutt et al.,  1992) from which procathepsin D  might po- 
tentially be delivered to the cell surface if sorting to lyso- 
somes  were  disrupted,  early  endosomes  could  be  an 
alternative  site  of  wortmannin  action;  kinetic  analysis 
would  not  distinguish  this  from  an  effect at  the  TGN. 
However, if early endosomes were the primary site of ac- 
tion  it  is  probable  that  the  majority of the  proenzyme 
would have remained cell associated in the absence of ex- 
tracellular M6P, since delivery to this compartment, unlike 
movement through the secretory pathway to the TGN, is 
dependent upon association with M6P receptors. In addi- 
tion, the apparent failure of wortmannin to prevent trans- 
port to lysosomes of procathepsin D  endocytosed by the 
ci-M6PR argues against the primary effect of the drug on 
lysosomal targeting being on elements  of the  endocytic 
pathway, although a  minor effect of the drug on move- 
ment between the cell surface and lysosomes cannot be 
completely excluded. 
The most probable primary site of wortmannin-induced 
mistargeting of lysosomal proenzymes is the TGN. How- 
ever, at present the precise mechanism by which the drug 
acts remains to be elucidated. Since lysosomal targeting of 
procathepsin D  in K-562 cells is completely inhibited by 
ammonium chloride (Davidson, H. W., unpublished  ob- 
servation) and hence M6P dependent, the observed effect 
would arise if any part of this receptor-mediated process 
were disrupted. Thus one trivial explanation is that wort- 
mannin interferes with the formation of the  recognition 
signal.  The  data  presented  above  clearly eliminate  this 
possibility as the proenzyme secreted in the presence of 
the drug was able to selectively bind to both cell associated 
and isolated ci-M6PRs.  Another possibility is that wort- 
mannin inhibits binding of lysosomal hydrolases to M6P 
receptors in the TGN. This could occur either following an 
alteration in the internal environment of the organelle (for 
example by acidification below pH 5.5), or by the preven- 
tion of receptor-ligand dissociation in the PLC (for exam- 
ple by alkalinization of this compartment) and consequent 
recycling of occupied receptors. Such a conclusion might 
be supported by the apparent lack of a stable TGN-associ- 
ated  pool  of  procathepsin  D,  although  it  is  uncertain 
whether the experimental conditions used, and total popu- 
lations of M6P receptors and competing ligands present, 
would permit detection of such a pool if it occurred. To 
date there have been no reported indications that PI3-K 
directly affects ion channels or pumps, or that wortmannin 
or LY294002 directly influence these molecules at the con- 
centrations used, and I  consider it unlikely to be the pri- 
mary cause of the procathepsin D  mistargeting presently 
Davidson PI 3-Kinase Involvement in Lysosomal Enzyme Transport  803 observed. Nevertheless the possibility that the inhibitors 
act directly or indirectly to prevent receptor ligand associ- 
ation and/or dissociation cannot be completely excluded at 
present. 
However, perhaps a more probable explanation of the 
observed  effects is  that  wortmannin  directly influences 
M6P receptor trafficking, either by the prevention of its 
recruitment into clathrin-coated buds on the TGN, inhibi- 
tion of budding and/or fusion of clathrin-coated vesicles, 
or by the prevention of recycling from the PLC. A  similar 
conclusion was also reached in a related study concurrent 
with my work (Brown et al., 1995). In this case the authors 
showed  that  treatment  of rat  clone  9  hepatocytes with 
wortmannin,  albeit at significantly higher concentrations 
than those used in the present study, dramatically changed 
the subcellular distribution of ci-M6PRs, causing a deple- 
tion from both PLCs and the cell surface, and an inferred 
accumulation in the TGN. Concurrent with this redistribu- 
tion of ci-M6PRs induced by wortmannin, or the structur- 
ally unrelated  PI3-K inhibitor LY294002  (Vlahos  et al., 
1994), Brown and coworkers also observed aberrant secre- 
tion of procathepsin D. Thus their data suggests that inhi- 
bition of PI3-K activity inhibits exit of ci-M6PRs from the 
TGN, but does not affect recycling from the PLC; a possi- 
bility which could not be excluded by the results of my 
study. Consistent with their conclusion, wortmannin does 
not prevent recycling of TGN38 from the cell surface to 
the TGN under conditions which cause redistribution of 
ci-M6PRs  (Reaves, B. J., and J. P.  Luzio, manuscript in 
preparation), while the demonstration in the present study 
that efficient targeting of procathepsin D rapidly resumed 
after removal of the inhibitor argues against the loss of re- 
ceptors from the PLC observed by Brown and coworkers 
being due to their degradation. 
Nevertheless, it remains unclear whether mistargeting of 
procathepsin  D  results  from  the  selective  inhibition  of 
M6P receptor recruitment into coated buds, or from the 
prevention of budding of clathrin coated membrane from 
the TGN. Wortmannin does not appear to significantly al- 
ter the amount of ~/-adaptin associated with the TGN in in- 
tact  NRK  cells,  affect AP1  adaptor  recruitment  to  the 
TGN in vitro (Seaman,  1995), nor alter the gross ultra- 
structure of the TGN (Brown et al., 1995). However, there 
is no indication as to how dynamic the pool of TGN-asso- 
ciated clathrin and adaptors is in the presence of PI3-K in- 
hibitors, nor whether clathrin-coated vesicles are formed 
from this organelle under these conditions. 
Another question which remains to be answered is the 
identity of the PI3-K involved in lysosomal enzyme target- 
ing:  In S.  cerevisiae, inactivation of Vps34p  almost com- 
pletely  abolishes  the  formation  of phosphatidylinositol 
3-phosphate (Schu et al., 1993), indicating that it is the ma- 
jor, if not only, PI3-K in these cells. In contrast mamma- 
lian cells possess at least four distinct PI3-K catalytic sub- 
units (Hiles et al., 1992; Hu et al., 1993; Stephens et al., 
1994a, b). Of these at least three are implicated in events 
associated with  ligand-activation of plasma membrane re- 
ceptors (Hiles et al., 1992; Hu et al., 1993; Stephens et al., 
1994b),  and  one  or  more  of them  may  be  involved in 
ligand-activated membrane trafficking events such as glu- 
cose transporter translocation and PDGF receptor sorting. 
However it appears unlikely that such enzymes would also 
be involved in constitutive transport events such as lysoso- 
mal  enzyme  trafficking.  Indeed  the  observation  in  the 
present  study that  half-maximal inhibition  of lysosomal 
targeting required  a  dose of LY294002 6--8-fold greater 
than that required to half-maximally inhibit insulin stimu- 
lated PI3-K activity and glucose transporter translocation 
(Cheatham et al., 1994)  suggests that an enzyme distinct 
from that implicated in ligand-activated events is involved 
in  lysosomal  transport.  Like  Vps34p,  but  unlike  other 
mammalian  PI3-Ks,  one  of  the  enzymes  identified  by 
Stephens and coworkers is specific for phosphatidylinosi- 
tol (Stephens et al.,  1994a). Again like Vps34p (Woschol- 
ski,  et al.,  1994),  this  enzyme is relatively insensitive  to 
wortmannin in vitro, with half-maximal activity at ~400 
nM (Stephens et al.,  1994a).  However such resistance is 
clearly incompatible with the observation in the present 
study, that half-maximal mistargeting  of procathepsin D 
occurred at 10-20 nM wortmannin, casting severe doubt 
on the hypothesis that it is the enzyme whose inhibition is 
responsible for the effect. 
Recently  a  cDNA  clone  encoding  part  of a  protein 
whose  sequence  is  highly  homologous  to  Vps34p,  and 
more closely related to VPS34 than other mammalian PI3- 
Ks, has been isolated from a  rat insulinoma  (Davidson, 
H. W., unpublished observation). A  full-length clone en- 
coding a protein immunologically and structurally similar 
to the rat "vps34 homologue" has been isolated from a hu- 
man cDNA library (Volinia et al., 1995; Davidson, H. W., 
and  M.  D.  Waterfield,  unpublished  observation).  This 
gene encodes a 95-kD PI-specific PI3-K which is inhibited 
by  wortmannin  in  the  low  nanomolar  range  and  by 
LY294002, consistent with the observations made in the 
present study. At present it remains to be shown that this 
gene indeed encodes the PI3-K involved in lysosomal en- 
zyme targeting. However it appears to be the best current 
candidate, and the probable involvement of a mammalian 
"vps34 homologue" in the movement of newly synthesized 
lysosomal hydrolases from the TGN to endosomes further 
supports  the  hypothesis that  the biochemical machinery 
governing this event is highly conserved in all eukaryotes. 
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